Your session is about to expire
← Back to Search
NA
Programmed Intermittent Epidural Bolus for Prolonged Labor (GLEAM Trial)
N/A
Waitlist Available
Led By Ronald B George, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Requests labor epidural analgesia requiring epidural maintenance with local anesthesia and opioid for planned vaginal delivery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during labor up to time of delivery
Awards & highlights
GLEAM Trial Summary
The GLEAM trial is a multicenter, pragmatic, cluster-randomized trial to assess the effects of programmed intermittent epidural bolus versus continuous epidural infusion on the rate of spontaneous vaginal delivery and several other clinically-relevant outcomes.
Eligible Conditions
- Prolonged Labor
GLEAM Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowGLEAM Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ delivery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~delivery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Spontaneous Vaginal Delivery
Secondary outcome measures
CEI rate
Cesarean Delivery
Epidural opioids used
+8 moreGLEAM Trial Design
2Treatment groups
Active Control
Group I: Programmed Intermittent Epidural BolusActive Control1 Intervention
Intermittent epidural bolus as the first line labor epidural analgesia maintenance infusion
Group II: Continuous Epidural InfusionActive Control1 Intervention
Continuous epidural infusion as the first line labor epidural analgesia maintenance infusion
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,513 Previous Clinical Trials
15,243,936 Total Patients Enrolled
Ronald B George, MDPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
105 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger